Loading
Jasper Therapeutics, Inc. Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest was filed 24 Sept 2025.
Jasper Therapeutics, Inc.: what insiders have been doing
Jasper Therapeutics, Inc., classified in the Health Care sector, is a listed company. Its insiders report their share dealings to SEC (Form 4). Jasper Therapeutics, Inc. has had no insider filing for more than a year; the last one goes back to 24 September 2025.
Since 2021, the database holds 11 purchases and 6 sales by insiders of the company.
Other companies in the same sector with recent insider buying flagged by our signals: Anixa Biosciences Inc and Vivos Inc. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Insider Decl.
40
Thresholds
n/a
Buy Volume
€15M
11 ops. · all time
Sell Volume
€216,854
6 ops. · all time
Who traded when
BuySaleJudith Anne Shizuru1 buy
Ron Martell1 buy
Svetlana Lucas1 buy
Thomas G. Wiggans1 buy
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
· cache
Last declaration on 24 September 2025
Declarations40 total
41,000 shares@ US$2.4383.0% of flowVoting Common StockSEC:0001213900-25-091105:0
Canonical exit: 21 Dec 2025 (T+90)
20,000 shares@ US$2.43100.0% of flowVoting Common StockSEC:0001213900-25-091104:0
Canonical exit: 21 Dec 2025 (T+90)
41,000 shares@ US$2.4331.1% of flowVoting Common StockSEC:0001213900-25-091099:0
Canonical exit: 21 Dec 2025 (T+90)
41,000 shares@ US$2.43100.0% of flowVoting Common StockSEC:0001213900-25-091096:0
Canonical exit: 21 Dec 2025 (T+90)
900 shares@ US$7.105.6% of flowVoting Common StockSEC:0001213900-24-108551:0
900 shares@ US$7.105.3% of flowVoting Common StockSEC:0001213900-24-078214:0
900 shares@ US$7.105.4% of flowVoting Common StockSEC:0001213900-24-052215:0
400 shares@ US$4.1735100.0% of flowVoting Common StockSEC:0001213900-24-051417:0
900 shares@ US$7.105.4% of flowVoting Common StockSEC:0001213900-24-021961:0
190,000 shares@ US$12.9534.6% of flowVoting Common StockSEC:0000950170-24-014017:0
Canonical exit: 8 May 2024 (T+90)
350,000 shares@ US$12.95100.0% of flowCommon Stock, par value $0.0001 per shareSEC:0000921895-24-000337:0
Canonical exit: 8 May 2024 (T+90)
10,000 shares@ US$0.64865.8% of flowVoting Common StockSEC:0001213900-23-091458:0
Canonical exit: 26 Feb 2024 (T+90)
10,000 shares@ US$0.63835.7% of flowVoting Common StockSEC:0001213900-23-089579:0
Canonical exit: 19 Feb 2024 (T+90)
10,000 shares@ US$0.59655.4% of flowVoting Common StockSEC:0001213900-23-088896:0
Canonical exit: 14 Feb 2024 (T+90)
87,531 shares@ US$0.8526.0% of flowVoting Common StockSEC:0001013762-23-003902:0
7,965 shares@ US$0.85089.9% of flowVoting Common StockSEC:0001013762-23-003901:0
37,126 shares@ US$0.8527.5% of flowVoting Common StockSEC:0001013762-23-003903:0
9,000 shares@ US$0.715.4% of flowVoting Common StockSEC:0001213900-23-048683:0
8,500 shares@ US$1.4417.0% of flowVoting Common StockSEC:0001213900-23-029888:0
7,000 shares@ US$1.48100.0% of flowVoting Common StockSEC:0001213900-23-029901:0
9,075 shares@ US$1.4903100.0% of flowVoting Common StockSEC:0001213900-23-029900:0
37,126 shares@ US$1.4645.3% of flowVoting Common StockSEC:0001213900-23-029893:0
87,531 shares@ US$1.4642.8% of flowVoting Common StockSEC:0001213900-23-029896:0
2,666,666 shares@ US$1.50100.0% of flowVoting Common StockSEC:0001209191-23-024058:0
Canonical exit: 27 Apr 2023 (T+90)
3,133,333 shares@ US$1.5065.4% of flowVoting Common StockSEC:0000899243-23-003059:0
Canonical exit: 27 Apr 2023 (T+90)
25 of 40 declarations
About Jasper Therapeutics, Inc.
Jasper Therapeutics, Inc. is a biopharmaceutical company focused on developing innovative therapies for hematological diseases. It employs cell biology-based approaches to enhance patient treatments.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
